BRPI0713792A8 - uso de derivados de estilbeno para tratamento e prevenção de infecções por fungos aquáticos - Google Patents

uso de derivados de estilbeno para tratamento e prevenção de infecções por fungos aquáticos

Info

Publication number
BRPI0713792A8
BRPI0713792A8 BRPI0713792A BRPI0713792A BRPI0713792A8 BR PI0713792 A8 BRPI0713792 A8 BR PI0713792A8 BR PI0713792 A BRPI0713792 A BR PI0713792A BR PI0713792 A BRPI0713792 A BR PI0713792A BR PI0713792 A8 BRPI0713792 A8 BR PI0713792A8
Authority
BR
Brazil
Prior art keywords
fungal infections
prevention
treatment
aquatic
stilbene derivatives
Prior art date
Application number
BRPI0713792A
Other languages
English (en)
Inventor
Polacheck Itzhack
Falk Rama
Tinman Simon
Original Assignee
Hadasit Medical Res Services And Development Limited
State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hadasit Medical Res Services And Development Limited, State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization filed Critical Hadasit Medical Res Services And Development Limited
Publication of BRPI0713792A2 publication Critical patent/BRPI0713792A2/pt
Publication of BRPI0713792A8 publication Critical patent/BRPI0713792A8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

uso de derivados de estilbeno para o tratamento e prevenção de infecções por fungos aquáticos. a invenção refere-se aos método de tratamento e prevenção de infecções por fungos quáticos em organismos aquáticos e métodos de desinfetar equipamento empregado em organismos aquáticos aumentado. os método compreendendo o uso de um ou mais derivado de estilbeno, incluindo derivados de ácidos 4,4'-bis-(1,3,5-triazinailamino)estilbeno-2,2'-dissulfônico.
BRPI0713792A 2006-06-27 2007-06-27 uso de derivados de estilbeno para tratamento e prevenção de infecções por fungos aquáticos BRPI0713792A8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US81661906P 2006-06-27 2006-06-27
US60/816.619 2006-06-27
PCT/IL2007/000784 WO2008001368A2 (en) 2006-06-27 2007-06-27 Use of stilbene derivatives for treatment and prevention of aquatic mold infections

Publications (2)

Publication Number Publication Date
BRPI0713792A2 BRPI0713792A2 (pt) 2012-11-06
BRPI0713792A8 true BRPI0713792A8 (pt) 2018-01-09

Family

ID=38846097

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0713792A BRPI0713792A8 (pt) 2006-06-27 2007-06-27 uso de derivados de estilbeno para tratamento e prevenção de infecções por fungos aquáticos

Country Status (6)

Country Link
US (1) US8377934B2 (pt)
EP (1) EP2043657A4 (pt)
CN (1) CN101563087B (pt)
AU (1) AU2007264670A1 (pt)
BR (1) BRPI0713792A8 (pt)
WO (1) WO2008001368A2 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108866149B (zh) * 2017-05-11 2021-10-15 首都医科大学附属北京天坛医院 一种用于真菌检测的新型荧光染色试剂、其应用以及真菌检测试剂盒
KR102718991B1 (ko) 2020-09-25 2024-10-16 씨제이제일제당 (주) 스틸벤계 화합물을 포함하는 항콕시듐증 조성물 및 이의 용도
CN113186299A (zh) * 2021-04-25 2021-07-30 中国水产科学研究院南海水产研究所 卵形鲳鲹刺激隐核虫病关联的snp分子标记及其引物和应用
CN115067246B (zh) * 2022-07-14 2023-06-27 淮北聚源渔业有限公司 一种鲈鱼孵化卵收集设备

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519280A1 (de) 1985-05-30 1986-12-04 Basf Ag, 6700 Ludwigshafen Stilbenderivate und fungizide, die diese verbindungen enthalten
DE3826058A1 (de) 1988-07-30 1990-02-08 Bayer Ag Mittel gegen fischparasiten
CN1044905A (zh) * 1989-02-16 1990-08-29 赫彻斯特股份公司 鱼和昆虫寄生虫对抗剂
US5124149A (en) 1990-11-07 1992-06-23 The United States Of America As Represented By The Secretary Of Agriculture Compositions and methods for biocontrol using fluorescent brighteners
SE9103113L (sv) 1991-10-24 1993-03-08 Eka Nobel Ab Saett att bekaempa laxlus(lepeophtheirus salmonis) vid odling av laxfiskar samt saett att framstaella ett medel haerfoer
US5879674A (en) 1992-02-18 1999-03-09 American Cyanamid Company Potentiation of epizootic viral infections of insects
JP3309104B2 (ja) 1992-02-20 2002-07-29 メレルダウファーマス−ティカルズ インコーポレイテッド ウイルス病治療用のスルホン酸誘導体類
DE4232561A1 (de) 1992-09-29 1994-03-31 Bayer Ag Bekämpfung von Fischparasiten
US5593678A (en) 1994-10-11 1997-01-14 University Of Georgia Research Foundation Protection of teleost fish
PT874549E (pt) 1995-12-11 2002-05-31 Novartis Ag Metodo de controlo de parasitas do peixe
US5852015A (en) 1997-01-27 1998-12-22 American Cyanamid Company Triazine containing anionic compounds useful as antiviral agents
GB9616139D0 (en) 1996-08-01 1996-09-11 Grampian Pharm Ltd Veterinary treatments
WO1998025456A1 (en) 1996-12-13 1998-06-18 Chemoxal S.A. Use of peracetic acid in fish farming
US5997846A (en) 1997-11-17 1999-12-07 Albert Einstein College Of Medicine Of Yeshiva University Method for detecting arthropods
US6175948B1 (en) * 1998-02-05 2001-01-16 Motorola, Inc. Method and apparatus for a waveform compiler
RU2241703C2 (ru) 1998-02-20 2004-12-10 Циба Спешиалти Кемикалз Холдинг Инк. Способ получения жидкой композиции, содержащей соединения стильбена
AU4683599A (en) 1998-06-25 2000-01-10 Collaborative Group, Ltd., The Beta(1,3)-glucan microfibril assembly assay
US6919452B1 (en) 2000-10-03 2005-07-19 Fuji Photo Film Co., Ltd Diaminostilbene derivatives
US6538031B1 (en) 1999-11-25 2003-03-25 Novartis Animal Health Us, Inc. Method of controlling sea lice infestation in fish
US6852498B2 (en) * 2001-01-25 2005-02-08 Syngenta Participations Ag Oomycete FtsZ-mt as a target for oomycete-specific antimicrobials
US7353362B2 (en) * 2003-07-25 2008-04-01 International Business Machines Corporation Multiprocessor subsystem in SoC with bridge between processor clusters interconnetion and SoC system bus
JP4275013B2 (ja) * 2004-06-21 2009-06-10 三洋電機株式会社 データフローグラフ処理装置、処理装置、リコンフィギュラブル回路。

Also Published As

Publication number Publication date
CN101563087B (zh) 2014-01-29
US20090252768A1 (en) 2009-10-08
BRPI0713792A2 (pt) 2012-11-06
EP2043657A2 (en) 2009-04-08
AU2007264670A1 (en) 2008-01-03
US8377934B2 (en) 2013-02-19
EP2043657A4 (en) 2014-07-16
WO2008001368A2 (en) 2008-01-03
WO2008001368A3 (en) 2009-04-30
CN101563087A (zh) 2009-10-21

Similar Documents

Publication Publication Date Title
BR112021022624A2 (pt) Compostos para o tratamento da doença de huntington
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
JO3235B1 (ar) مركبات بيررولوبيريميدين و استعمالاتها
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
CY1121135T1 (el) Ενωσεις υποκατεστημενης τετρακυκλιnhς για την θεραπευτικη αγωγη φλεγμονωδων διαταραχων του δερματος
DOP2009000165A (es) Derivados de oxindol sustituido, medicamentos que los comprenden y uso de los mismos
EA201000563A1 (ru) Триазолпиридиновые ингибиторы 11-бета- гидроксистероид - дегидрогеназы типа i
ECSP099413A (es) COMPUESTOS A BASE DE 4 - fenil - 6 - (2,2,2 - trifluoro - 1 - feniletoxi)pirimidina Y MÉTODOS PARA SU EMPLEO
NO20084749L (no) Organiske forbindelser og deres anvendelser
EA200800006A1 (ru) Триазолопиридины в качестве ингибиторов 11-бета-гидроксистероиддегидрогеназы типа i
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
EA200802118A1 (ru) Обладающие ингибирующей активностью в отношении mnk1/mnk2 тиенопиримидины, предназначенные для применения в фармацевтических композициях
MX2009000657A (es) Composiciones y metodos para el tratamiento de mucositis.
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
BRPI0510142A (pt) compostos, composições e métodos para estabilizar a transtiretina e inibir a duplicação defeituosa da transtiretina
BR112013032711A2 (pt) composições farmacêuticas compreendendo sulbactam e inibidor de beta-lactamase
EA200970529A1 (ru) Антивирусная композиция и способ ее применения
NO20093542L (no) Inhibering av tumormetastase ved hjelp av anti-neuropilin 2-antistoffer
BRPI0718469A2 (pt) Uso de um antagonista de interleucina 1 (il-1), método para tratar, inibir, ou melhorar pseudogota, uso de um ou mais agentes terapêuticos, e, produto.
BRPI0720169A2 (pt) Composto ou um sal do mesmo, prodroga, agente farmacêutico, método para a profilaxia ou tratamento de câncer, e, uso do composto
CL2007002387A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de artritis y dolor.
BRPI0416268A (pt) composições de delta-9-thc e métodos para o tratamento de sintomas associados à esclerose múltipla
JO2581B1 (en) Substituted Arylsulfonamides
CL2007003643A1 (es) Composicion farmaceutica de azimilidina que comprende 0,5% a aproximadamente 2,5% (w/w) de agua; y uso para el tratamiento de arritmias cardiacas.

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law
B08G Application fees: restoration
B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa)

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B06U Preliminary requirement: requests with searches performed by other patent offices: suspension of the patent application procedure
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements